The umami peptide AHSVRFY from Parma ham lowered blood pressure by 13.9 mmHg in hypertensive rats after oral dosing, working through a digestion-released fragment FY that improves blood vessel function.
-13.9 mmHgSingle oral dose of the ham-derived peptide significantly reduced systolic blood pressure in hypertensive rats
What the researchers found
Oral AHSVRFY reduced SBP by 13.9 ± 2.7 mmHg in SHRs through its GI-released dipeptide FY (ACE IC50 = 45.11 μM), which was absorbed intact and improved vascular endothelial function via NO/ET-1 modulation.
Why it matters
Validates a "digestion-activation-delivery" framework showing that food peptides can be designed to release active fragments during digestion, bridging food science and pharmaceutical development.
How the study worked
Oral dosing in spontaneously hypertensive rats with blood pressure monitoring, simulated GI digestion, plasma peptide identification, endothelial cell (HUVEC) assays, and molecular docking/dynamics simulations.
What this study cannot tell us
Rat model; human blood pressure effects may differ. Single-dose study; chronic effects unknown. The 13.9 mmHg reduction in rats may not translate proportionally to humans.
How to read the evidence
Well-designed preclinical study with in vivo, in vitro, and computational validation. Establishes mechanism but human data needed.
When this study was published
Published in 2025.
The bigger picture
This study demonstrates a principled approach to developing food-derived peptide antihypertensives: understanding exactly how digestion transforms the parent peptide into the actual bioactive form.
Questions still open
- Would regular Parma ham consumption provide meaningful blood pressure reduction in humans?
- Can FY be developed as a functional food ingredient or nutraceutical?
- How does FY compare to captopril for chronic antihypertensive use?
Common questions
Can eating Parma ham lower blood pressure?
How does a food peptide lower blood pressure?
Read the original research
An in vivo study of the antihypertensive effects of the umami peptide AHSVRFY from Parma ham and its intestinal digestion.
Food & function, 17(1), 315-328
Citation
Ding, Qian; Wang, Tianyu; Dang, Kuo; Wang, Yanli; Pan, Daodong; Xia, Qiang; Gao, Xinchang; Dang, Yali. (2026). An in vivo study of the antihypertensive effects of the umami peptide AHSVRFY from Parma ham and its intestinal digestion.. Food & function, 17(1), 315-328. https://doi.org/10.1039/d5fo03304g